Ilknur Tugal-Tutkun

Prof. Ilknur Tugal-Tutkun

Department of Ophthalmology, University of Istanbul, Istanbul, Turkey
orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 September 2008 in International Ophthalmology
Verified
Journal Article
Closed access
PDF file
T(The Angiography Scoring for Uveitis Working Group (ASUWOG)
The Angiography Scoring for Uveitis Working Group (ASUWOG)
ITIlknur Tugal-Tutkun
Ilknur Tugal-Tutkun
CHCarl P. Herbort
Carl P. Herbort
MKMoncef Khairallah
Moncef Khairallah

9 May 2009 in International Ophthalmology
Verified
Journal Article
Closed access
PDF file
ITIlknur Tugal-Tutkun
Ilknur Tugal-Tutkun
CHCarl P. Herbort
Carl P. Herbort

4 May 2006 in Graefe's Archive for Clinical and Experimental Ophthalmology
Verified
Journal Article
Closed access
PDF file
ITIlknur Tugal-Tutkun
Ilknur Tugal-Tutkun
EGEsra Güney-Tefekli
Esra Güney-Tefekli
MUMeri Urgancioglu
Meri Urgancioglu

1 January 2009 in Middle East African Journal of Ophthalmology
Verified
Journal Article
Open access
ITIlknur Tugal-Tutkun
Ilknur Tugal-Tutkun
The initial manifestation of the disease in 10-15% of the patients. Anterior uveitis is always nongranulomatous. Diffuse vitritis, retinal infiltrates, sheathing of predominantly retinal veins, and occlusive vasculitis are the typical signs of posterior segment inflammation. Spontaneous resolution of acute inflammatory signs is a diagnostic feature. Fundus fluorescein angiography is the gold standard in monitoring inflammatory activity. Laser flare photometry is a useful noninvasive tool since flare readings correlate with fluorescein angiographic leakage. The most common complications are cataract, maculopathy, and optic atrophy. Male patients have a more severe disease course and worse visual prognosis. Immunomodulatory therapy is indicated in all patients with posterior segment involvement. Corticosteroids combined with azathioprine and/or cyclosporine is used initially. Biologic agents, including interferon alfa and infliximab, are used in resistant cases. Visual prognosis has improved in recent years with an earlier and more aggressive use of immunomodulatory therapy and the use of biologic agents in resistant cases....

1 October 2011 in Archives of Ophthalmology (1950)
Verified
Journal Article
Open access
PDF file
ITIlknur Tugal-Tutkun
Ilknur Tugal-Tutkun
SOSumru Onal
Sumru Onal
AGAylin Garip
Aylin Garip
MTMuhittin Taskapili
Muhittin Taskapili
HKHaluk Kazokoglu
Haluk Kazokoglu
PKPhilippe Kestelyn
Philippe Kestelyn
Research from JAMA Ophthalmology — Bilateral Acute Iris Transillumination

27 May 2008 in Graefe's Archive for Clinical and Experimental Ophthalmology
Verified
Journal Article
Closed access
PDF file
ITIlknur Tugal-Tutkun
Ilknur Tugal-Tutkun
KCKürsat Cingü
Kürsat Cingü
NKNur Kir
Nur Kir
BYBaris Yeniad
Baris Yeniad
MUMeri Urgancioglu
Meri Urgancioglu
AGAhmet Gül
Ahmet Gül